Venus Concept (VERO) Competitors $2.62 -0.34 (-11.36%) Closing price 07/3/2025 03:51 PM EasternExtended Trading$2.58 -0.03 (-1.15%) As of 07/3/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. LYRA, DHAI, IINN, INBS, WOK, PAVM, BTCY, CODX, SSKN, and NUROShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Lyra Therapeutics (LYRA), DIH Holding US (DHAI), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), PAVmed (PAVM), Biotricity (BTCY), Co-Diagnostics (CODX), Strata Skin Sciences (SSKN), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry. Venus Concept vs. Its Competitors Lyra Therapeutics DIH Holding US Inspira Technologies OXY B.H.N. Intelligent Bio Solutions WORK Medical Technology Group PAVmed Biotricity Co-Diagnostics Strata Skin Sciences NeuroMetrix Venus Concept (NASDAQ:VERO) and Lyra Therapeutics (NASDAQ:LYRA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Which has more risk and volatility, VERO or LYRA? Venus Concept has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Lyra Therapeutics has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Which has stronger earnings and valuation, VERO or LYRA? Venus Concept has higher revenue and earnings than Lyra Therapeutics. Lyra Therapeutics is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenus Concept$64.83M0.06-$47M-$76.30-0.03Lyra Therapeutics$1.53M7.84-$93.43M-$60.50-0.15 Is VERO or LYRA more profitable? Venus Concept has a net margin of -81.26% compared to Lyra Therapeutics' net margin of -6,711.39%. Lyra Therapeutics' return on equity of -295.52% beat Venus Concept's return on equity.Company Net Margins Return on Equity Return on Assets Venus Concept-81.26% -752.29% -54.52% Lyra Therapeutics -6,711.39%-295.52%-66.95% Do institutionals and insiders hold more shares of VERO or LYRA? 87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 95.6% of Lyra Therapeutics shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by company insiders. Comparatively, 3.3% of Lyra Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer VERO or LYRA? Lyra Therapeutics has a consensus price target of $100.00, suggesting a potential upside of 1,009.26%. Given Lyra Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Lyra Therapeutics is more favorable than Venus Concept.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Venus Concept 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lyra Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to VERO or LYRA? In the previous week, Lyra Therapeutics had 1 more articles in the media than Venus Concept. MarketBeat recorded 2 mentions for Lyra Therapeutics and 1 mentions for Venus Concept. Lyra Therapeutics' average media sentiment score of 0.75 beat Venus Concept's score of 0.52 indicating that Lyra Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Venus Concept 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lyra Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLyra Therapeutics beats Venus Concept on 10 of the 16 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.71M$6.85B$5.50B$9.02BDividend YieldN/A1.23%5.38%4.10%P/E Ratio-0.0326.6327.6020.30Price / Sales0.0696.66369.54104.24Price / CashN/A20.9736.6357.47Price / Book0.614.748.055.68Net Income-$47M$173.18M$3.18B$249.13M7 Day Performance19.95%1.33%2.82%3.30%1 Month Performance9.41%-0.41%3.69%5.20%1 Year Performance-61.03%28.42%35.41%21.37% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept1.2098 of 5 stars$2.62-11.4%N/A-61.0%$3.71M$64.83M-0.03410LYRALyra Therapeutics2.3118 of 5 stars$8.96-1.6%$100.00+1,016.1%-35.6%$12.07M$1.53M-0.1550Positive NewsGap DownDHAIDIH Holding US0.7083 of 5 stars$0.24-2.4%N/A-92.1%$11.88M$64.47M-0.82N/AGap DownIINNInspira Technologies OXY B.H.N.2.8754 of 5 stars$0.85flat$2.00+135.3%-9.6%$10.73MN/A0.0020INBSIntelligent Bio Solutions0.3303 of 5 stars$1.72+12.4%N/A+1.1%$10.57M$3.11M0.0010WOKWORK Medical Technology GroupN/A$0.69-3.5%N/AN/A$10.43M$11.51M0.00226Positive NewsGap DownPAVMPAVmed3.9733 of 5 stars$0.60+0.1%$19.00+3,065.1%-15.7%$10.26M$2.99M0.8590BTCYBiotricityN/A$0.37-7.9%N/A-46.5%$10.02M$12.06M-0.3440News CoverageGap DownCODXCo-Diagnostics4.2117 of 5 stars$0.28+6.7%$5.50+1,862.9%-77.6%$9.41M$3.71M-0.24100Gap UpSSKNStrata Skin Sciences2.8932 of 5 stars$2.29+1.8%$6.00+162.0%-23.2%$9.39M$33.56M-1.01120Gap UpNURONeuroMetrixN/A$4.55+4.4%N/A+22.0%$9.37M$3.03M-0.9920High Trading Volume Related Companies and Tools Related Companies LYRA Alternatives DHAI Alternatives IINN Alternatives INBS Alternatives WOK Alternatives PAVM Alternatives BTCY Alternatives CODX Alternatives SSKN Alternatives NURO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
